Cargando…
In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells.
Aplidine is a new marine anti-cancer depsipeptide isolated from the Mediterranean tunicate Aplidium albicans. We have evaluated its antiproliferative action against a variety of freshly explanted human tumour specimens. Concentration ranges of 0.01-1.0 microM and 0.0001-1.0 microM were used in short...
Autores principales: | Depenbrock, H., Peter, R., Faircloth, G. T., Manzanares, I., Jimeno, J., Hanauske, A. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062976/ https://www.ncbi.nlm.nih.gov/pubmed/9743292 |
Ejemplares similares
-
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine
por: Erba, E, et al.
Publicado: (2002) -
Effect of Aplidin in acute lymphoblastic leukaemia cells
por: Erba, E, et al.
Publicado: (2003) -
Antiangiogenic activity of aplidine, a new agent of marine origin
por: Taraboletti, G, et al.
Publicado: (2004) -
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™
por: Losada, A, et al.
Publicado: (2004) -
Clonogenic cell survival in cryopreserved human tumour cells.
por: Selby, P. J., et al.
Publicado: (1981)